Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors

QDEL – Quidel Corporation

QuidelOrtho Corporation
QDEL
$28.82
Name : QuidelOrtho Corporation
Sector : Healthcare
Industry: Medical Devices
Mark. Cap: $1,953,036,416.00
EPSttm : -5.22
finviz dynamic chart for QDEL
QuidelOrtho Corporation
$28.82
0.17%
$0.05

Float Short %

6.11

Margin Of Safety %

Put/Call OI Ratio

0.66

EPS Next Q Diff

-0.04

EPS Last/This Y

32.93

EPS This/Next Y

0.83

Price

28.81

Target Price

47.38

Analyst Recom

1.9

Performance Q

-17.4

Relative Volume

0.92

Beta

0.08

Ticker: QDEL




20 items of 1

DateSymbolLastP/C OIP/C VolTotal OI
2025-06-02QDEL29.671.180.0018612
2025-06-03QDEL30.271.180.0018630
2025-06-04QDEL31.061.180.4518632
2025-06-05QDEL29.881.180.3018648
2025-06-06QDEL29.51.170.4218775
2025-06-09QDEL30.21.1823.7118790
2025-06-10QDEL30.941.180.9018798
2025-06-11QDEL31.011.181.1118823
2025-06-12QDEL29.91.180.0118864
2025-06-13QDEL28.911.1714.4818883
2025-06-16QDEL29.241.150.0618630
2025-06-17QDEL28.041.143.6018636
2025-06-18QDEL28.361.1415.0018574
2025-06-20QDEL28.021.112.7218327
2025-06-23QDEL27.640.670.369837
2025-06-24QDEL28.660.670.069893
2025-06-25QDEL28.120.670.149950
2025-06-26QDEL28.70.670.289981
2025-06-27QDEL28.860.660.0410024
2025-06-30QDEL28.820.660.7710069
DateSymbolLastP/C OIP/C VolTotal OI
20 items Current Page1 of 1




20 items of 1

DateTickerPriceCurrent Quarter Growth EstimateEBIT EstimationAverage EPS Estimate Current Year
2025-06-02QDEL29.65117.4538.02.38
2025-06-03QDEL30.29117.4547.52.38
2025-06-04QDEL31.08117.4548.32.38
2025-06-05QDEL29.90103.6537.12.38
2025-06-06QDEL29.50103.6541.52.38
2025-06-09QDEL30.21103.6547.62.38
2025-06-10QDEL30.93103.6547.82.38
2025-06-11QDEL30.99106.0544.12.39
2025-06-12QDEL29.88106.0537.72.39
2025-06-13QDEL28.90106.0538.22.39
2025-06-16QDEL29.20106.0545.52.39
2025-06-17QDEL28.02106.0536.92.39
2025-06-18QDEL28.33106.0545.52.39
2025-06-20QDEL28.03106.0542.02.39
2025-06-23QDEL27.64106.0541.62.39
2025-06-24QDEL28.67106.0549.72.39
2025-06-25QDEL28.10106.0540.52.39
2025-06-26QDEL28.72106.0547.32.39
2025-06-27QDEL28.85106.0544.62.39
2025-06-30QDEL28.81106.0543.42.39
DateTickerPriceCurrent Quarter Growth EstimateEBIT EstimationAverage EPS Estimate Current Year
20 items Current Page1 of 1




19 items of 1

DateTickerInsider TransactionsInstitutional TransactionsFloat Short
2025-06-02QDEL0.433.436.39
2025-06-03QDEL0.433.436.39
2025-06-04QDEL0.433.436.39
2025-06-05QDEL0.433.436.39
2025-06-06QDEL0.433.436.39
2025-06-09QDEL0.433.366.39
2025-06-10QDEL0.433.366.39
2025-06-11QDEL0.433.365.90
2025-06-12QDEL0.433.365.90
2025-06-13QDEL0.433.365.90
2025-06-16QDEL0.003.265.90
2025-06-18QDEL0.003.265.90
2025-06-20QDEL0.003.265.90
2025-06-23QDEL0.003.595.90
2025-06-24QDEL0.003.595.90
2025-06-25QDEL0.003.595.90
2025-06-26QDEL0.003.596.14
2025-06-27QDEL0.003.596.11
2025-06-30QDEL0.003.596.11
DateTickerInsider TransactionsInstitutional TransactionsFloat Short
19 items Current Page1 of 1

Last Quarter Act. EPS

0.74

Avg. EPS Est. Current Quarter

Avg. EPS Est. Next Quarter

0.7

Insider Transactions

Institutional Transactions

3.59

Beta

0.08

Average Sales Estimate Current Quarter

610

Average Sales Estimate Next Quarter

693

Fair Value

Quality Score

47

Growth Score

51

Sentiment Score

43

Actual DrawDown %

90.6

Max Drawdown 5-Year %

-91.9

Target Price

47.38

P/E

Forward P/E

8.92

PEG

P/S

0.7

P/B

0.65

P/Free Cash Flow

EPS

-4.96

Average EPS Est. Cur. Y​

2.39

EPS Next Y. (Est.)

3.22

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

-12.07

Relative Volume

0.92

Return on Equity vs Sector %

-35.8

Return on Equity vs Industry %

-30.4

EPS 1 7Days Diff

EPS 1 30Days Diff

0.05

EBIT Estimation

543.4
QuidelOrtho Corporation
Sector: Healthcare
Industry: Medical Devices
Employees: 6600
QuidelOrtho Corporation provides diagnostic testing solutions. The company operates through Labs, Transfusion Medicine, Point of Care, and Molecular Diagnostics business units. The Labs business unit provides clinical chemistry laboratory instruments and tests that measure target chemicals in bodily fluids for the evaluation of health and the clinical management of patients; immunoassay laboratory instruments and tests, which measure proteins as they act as antigens in the spread of disease, antibodies in the immune response spurred by disease, or markers of proper organ function and health; testing products to detect and monitor disease progression across a spectrum of therapeutic areas; and specialized diagnostic solutions. The Transfusion Medicine business unit offers immunohematology instruments and tests used for blood typing to ensure patient-donor compatibility in blood transfusions; and donor screening instruments and tests used for blood and plasma screening for infectious diseases. The Point of Care business unit provides instruments and tests to provide rapid results across a continuum of POC settings. The Molecular Diagnostics business unit offers polymerase chain reaction thermocyclers; amplification systems; and sample-to-result molecular instruments and tests for syndromic infectious disease diagnostics. The company sells its products directly to end users through a direct sales force; and through a network of distributors for professional use in physician offices, hospitals, clinical laboratories, reference laboratories, urgent care clinics, universities, retail clinics, pharmacies, wellness screening centers, blood banks, and donor centers, as well as for individual, non-professional, and over-the-counter use. It operates in North America, Europe, the Middle East, Africa, China, and internationally. The company was incorporated in 1979 and is headquartered in San Diego, California.
stock quote shares QDEL – Quidel Corporation Stock Price stock today
news today QDEL – Quidel Corporation stock forecast ,stock prediction 2023 2024 2025
marketwatch QDEL – Quidel Corporation yahoo finance google finance
stock history QDEL – Quidel Corporation invest stock market
stock prices QDEL premarket after hours
ticker QDEL fair value insiders trading